Short-term effects of comprehensive pulmonary rehabilitation and its maintenance in patients with idiopathic pulmonary fibrosis: A randomized controlled trial

Journal of Clinical Medicine

Volumn 9, Issue 5, 2020, Pages

  Jarosch, Inga ^a,b   Schneeberger, Tessa ^a,b   Gloeckl, Rainer ^a,b   Kreuter, Michael ^c,d   Frankenberger, Marion ^e   Neurohr, Claus ^f   Prasse, Antje ^g   Freise, Julia ^g   Behr, Juergen ^e   Hitzl, Wolfgang ^h   Koczulla, Andreas R ^a,b,i   Kenn, Klaus ^a,b  

^a Schoenau am Koenigssee   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Member of the German Center for Lung Research   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f ROBERT BOSCH GMBH   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h PARACELSUS MEDICAL UNIVERSITY   (Austria)

ⁱ UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Exercise; Idiopathic pulmonary fibrosis; Pulmonary rehabilitation; Quality of life

Indexed keywords

CARBON MONOXIDE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; BORG SCALE; BREATHING EXERCISE; CHRONIC RESPIRATORY QUESTIONNAIRE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPRESSION; DYSPNEA; EMOTIONALITY; EXERCISE; FATIGUE; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH CARE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MAINTENANCE THERAPY; MALE; MIDDLE AGED; MULTICENTER STUDY; NONINVASIVE VENTILATION; OXYGEN THERAPY; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESISTANCE TRAINING; SCORING SYSTEM; SHORT COURSE THERAPY; SHORT FORM 36 MENTAL COMPONENT SUMMARY SCORE; SHORT FORM 36 PHYSICAL COMPONENT SUMMARY SCORE; SIX MINUTE WALK TEST; TOTAL LUNG CAPACITY;

EID: 85097214070     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm9051567     Document Type: Article

References (26)

1. Lederer, D.J.; Martinez, F.J. Idiopathic Pulmonary Fibrosis. N. Engl. J. Med. 2018, 378, 1811–1823. [CrossRef]
2. Raghu, G.; Collard, H.R.; Egan, J.J.; Martinez, F.J.; Behr, J.; Brown, K.K.; Lynch, D.A. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011, 183, 788–824. [CrossRef]
3. Kreuter, M.; Swigris, J.; Pittrow, D.; Geier, S.; Klotsche, J.; Prasse, A.; Grohé, C. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: Longitudinal data from the INSIGHTS-IPF registry. Respir. Res. 2019, 20, 59. [CrossRef] [PubMed]
4. Bahmer, T.; Kirsten, A.M.; Waschki, B.; Rabe, K.F.; Magnussen, H.; Kirsten, D.; Watz, H. Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis. BMC Pulm. Med. 2017, 17, 104. [CrossRef] [PubMed]
5. Spruit, M.A.; Singh, S.J.; Garvey, C.; ZuWallack, R.; Nici, L.; Rochester, C.; Pitta, F. An official American Thoracic Society/European Respiratory Society statement: Key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013, 188, e13–e64. [CrossRef] [PubMed]
6. Dowman, L.; Hill, C.J.; Holland, A.E. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst. Rev. 2014, 10, CD006322. [CrossRef]
7. Huppmann, P.; Sczepanski, B.; Boensch, M.; Winterkamp, S.; Schönheit-Kenn, U.; Neurohr, C.; Kenn, K. Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease. Eur. Respir. J. 2013, 42, 444–453. [CrossRef]
8. Holland, A.E.; Hill, C.J.; Conron, M.; Munro, P.; McDonald, C.F. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008, 63, 549–554. [CrossRef]
9. Dowman, L.M.; McDonald, C.F.; Hill, C.J.; Lee, A.L.; Barker, K.; Boote, C.; Gillies, R. The evidence of benefits of exercise training in interstitial lung disease: A randomised controlled trial. Thorax 2017, 72, 610–619. [CrossRef]
10. Perez-Bogerd, S.; Wuyts, W.; Barbier, V.; Demeyer, H.; Van Muylem, A.; Janssens, W.; Troosters, T. Short and long-term effects of pulmonary rehabilitation in interstitial lung diseases: A randomised controlled trial. Respir Res 2018, 19, 182. [CrossRef]
11. Sharp, C.; McCabe, M.; Hussain, M.J.; Dodd, J.W.; Lamb, H.; Adamali, H.; Smith, D. Duration of benefit following completion of pulmonary rehabilitation in interstitial lung disease-an observational study. QJM Mon. J. Assoc. Phys. 2017, 110, 17–22. [CrossRef] [PubMed]
12. Holland, A.E.; Hill, C.J.; Glaspole, I.; Goh, N.; McDonald, C.F. Predictors of benefit following pulmonary rehabilitation for interstitial lung disease. Respir. Med. 2012, 106, 429–435. [CrossRef] [PubMed]
13. Gloeckl, R.; Heinzelmann, I.; Baeuerle, S.; Damm, E.; Schwedhelm, A.L.; Diril, M.; Kenn, K. Effects of whole body vibration in patients with chronic obstructive pulmonary disease—A randomized controlled trial. Respir. Med. 2012, 106, 75–83. [CrossRef]
14. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002, 166, 111–117. [CrossRef] [PubMed]
15. Kim, E.S.; Choi, S.M.; Lee, J.; Park, Y.S.; Lee, C.H.; Yim, J.J.; Lee, S.M. Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest 2015, 147, 430–437. [CrossRef] [PubMed]
16. Ley, B.; Ryerson, C.J.; Vittinghoff, E.; Ryu, J.H.; Tomassetti, S.; Lee, J.S.; King, T.E. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 2012, 156, 684–691. [CrossRef]
17. Singh, S.J.; Puhan, M.A.; Andrianopoulos, V.; Hernandes, N.A.; Mitchell, K.E.; Hill, C.J.; Carlin, B.W. An official systematic review of the European Respiratory Society/American Thoracic Society: Measurement properties of field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1447–1478. [CrossRef]
18. Puhan, M.A.; Frey, M.; Büchi, S.; Schünemann, H.J. The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease. Health Qual. Life Outcomes 2008, 6, 46. [CrossRef]
19. Arizono, S.; Taniguchi, H.; Sakamoto, K.; Kondoh, Y.; Kimura, T.; Kataoka, K.; Kozu, R. Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis. Respir. Care 2014, 59, 1108–1115. [CrossRef]
20. Vainshelboim, B.; Oliveira, J.; Fox, B.D.; Soreck, Y.; Fruchter, O.; Kramer, M.R. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung 2015, 193, 345–354. [CrossRef]
21. Ryerson, C.J.; Cayou, C.; Topp, F.; Hilling, L.; Camp, P.G.; Wilcox, P.G.; Garvey, C. Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study. Respir. Med. 2014, 108, 203–210. [CrossRef] [PubMed]
22. Holland, A.E.; Spruit, M.A.; Troosters, T.; Puhan, M.A.; Pepin, V.; Saey, D.; Wanger, J. An official European Respiratory Society/American Thoracic Society technical standard: Field walking tests in chronic respiratory disease. Eur. Respir. J. 2014, 44, 1428–1446. [CrossRef] [PubMed]
23. Mesquita, R.; Vanfleteren, L.E.; Franssen, F.M.; Sarv, J.; Taib, Z.; Groenen, M.T.; Spruit, M.A. Objectively identified comorbidities in COPD: Impact on pulmonary rehabilitation outcomes. Eur. Respir. J. 2015, 46, 545–548. [CrossRef] [PubMed]
24. Janssens, T.; De Peuter, S.; Stans, L.; Verleden, G.; Troosters, T.; Decramer, M.; Van den Bergh, O. Dyspnea perception in COPD: Association between anxiety, dyspnea-related fear, and dyspnea in a pulmonary rehabilitation program. Chest 2011, 140, 618–625. [CrossRef]
25. Maurer, J.; Rebbapragada, V.; Borson, S.; Goldstein, R.; Kunik, M.E.; Yohannes, A.M.; Hanania, N.A. Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest 2008, 134 (Suppl. 4), 43S–56S. [CrossRef]
26. Zhou, Y.H.; Mak, Y.W. Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study. Int. J. Environ. Res. Public Health 2017, 14, 1277. [CrossRef]